Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-fo

Related Keywords

Rhode Island ,United States ,Boston ,Massachusetts ,Louisiana ,Harvard University ,Washington ,Alaska ,Joynt Maddox ,Jie Zheng ,Jodyw Zylke ,Deanna Chyn ,Michaell Barnett ,Kristin Walter ,International Classification Of Diseases ,Dartmouth College ,National Institutes Of Health ,Centene Corp ,Geisel School Of Medicine ,Department Of Health ,Institute Inc ,Blood Institute ,National Heart ,Dartmouth Institute For Health ,Agency For Healthcare Research ,National Institute On Aging ,Current Procedural Terminology ,International Classification ,Ninth Revision ,Medicare Advantage ,Deputy Editor ,Public Health ,Health Policy ,Interest Disclosures ,National Institutes ,National Institute ,Healthcare Research ,Drs Meara ,Associate Editor ,Dartmouth Institute ,Clinical Practice ,Geisel School ,